This was followed by studies confirming that blood neuroendocrine synaptic proteins, such as GAP43, SNAP25, neurogranin, and synaptotagmin 1, can be used as reliable biomarkers to predict AD 5−7 years before cognitive decline.207. This evidence concerns the gene SNAP25 and Alzheimer disease.